• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

色甘酸钠治疗期间出现伴有嗜酸性粒细胞增多的肺部浸润及泌尿系统症状。病例报告。

Pulmonary infiltrates with eosinophilia and urinary symptoms during disodium cromoglycate treatment. A case report.

作者信息

Repo U K, Nieminen P

出版信息

Scand J Respir Dis. 1976;57(1):1-4.

PMID:818704
Abstract

A 64-year-old asthmatic woman began to suffer from urinary irritation after 5 months' treatment with disodium cromoglycate. After 10 months she contracted, additionally, a dry, hacking cough and gradually increasing exercise-induced dyspnoea. Chest X-ray revealed scattered, micronodular infiltrations in both lungs, and her spirogram was clearly restrictive. Peripheral blood showed eosinophilia of 23.5%. Urine was clean. When DSCG was withdrawn, her urinary symptoms and cough disappeared overnight, and her dyspnoea improved within weeks, as did her chest X-ray. Inhalation provocation test with DSCG 2 months later resulted in an immediate asthmatic reaction followed by a possible delayed-type reaction 9 hours later. Disodium cromoglycate is regarded as the possible aetiologic agent.

摘要

一名64岁的哮喘女性在接受色甘酸钠治疗5个月后开始出现尿路刺激症状。10个月后,她又出现了干咳、阵咳,并逐渐出现运动性呼吸困难加重。胸部X线显示双肺散在微小结节浸润,肺功能检查显示明显的限制性通气障碍。外周血嗜酸性粒细胞增多至23.5%。尿液检查正常。停用色甘酸钠后,她的尿路症状和咳嗽在一夜之间消失,呼吸困难在数周内改善,胸部X线表现也有所改善。2个月后进行色甘酸钠吸入激发试验,立即出现哮喘反应,9小时后可能出现迟发型反应。色甘酸钠被认为是可能的病因。

相似文献

1
Pulmonary infiltrates with eosinophilia and urinary symptoms during disodium cromoglycate treatment. A case report.色甘酸钠治疗期间出现伴有嗜酸性粒细胞增多的肺部浸润及泌尿系统症状。病例报告。
Scand J Respir Dis. 1976;57(1):1-4.
2
[A case of bronchial asthma and PIE Syndrome induced by disodium cromoglycate].一例由色甘酸钠诱发的支气管哮喘和PIE综合征
Nihon Kyobu Shikkan Gakkai Zasshi. 1989 Jan;27(1):87-91.
3
Asthma and urticaria during disodium cromoglycate treatment. A case report.色甘酸钠治疗期间的哮喘和荨麻疹。病例报告。
Scand J Respir Dis. 1977 Jun;58(3):145-50.
4
Induced sputum in children with newly diagnosed mild asthma: the effect of 6 months of treatment with budesonide or disodium cromoglycate.新诊断轻度哮喘儿童的诱导痰:布地奈德或色甘酸钠治疗6个月的效果
Allergy. 2004 Aug;59(8):839-44. doi: 10.1111/j.1398-9995.2004.00504.x.
5
Pulmonary infiltrates with eosinophilia in an asthmatic patient treated with disodium cromoglycate.接受色甘酸钠治疗的哮喘患者出现伴有嗜酸性粒细胞增多的肺部浸润。
Lancet. 1972 Nov 11;2(7785):1032. doi: 10.1016/s0140-6736(72)92446-4.
6
[Assessment of the amount of drug deposited in the lungs of asthmatic children using disodium cromoglycate as the marker].[以色甘酸钠为标志物评估哮喘儿童肺部药物沉积量]
Arerugi. 1993 Aug;42(8):907-13.
7
Intratracheal dosing with disodium cromoglycate inhibits late asthmatic response by attenuating eicosanoid production in guinea pigs.
Eur J Pharmacol. 2004 Aug 16;497(1):97-104. doi: 10.1016/j.ejphar.2004.06.033.
8
Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate.一种用于间羟异丙肾上腺素和色甘酸二钠固定复方产品的新型无氟里昂定量吸入器的耐受性及体内性能
Arzneimittelforschung. 1998 Jun;48(6):663-7.
9
Preventive effect and duration of action of disodium cromoglycate and procaterol on exercise-induced asthma in asthmatic children.色甘酸钠与丙卡特罗对哮喘儿童运动诱发性哮喘的预防作用及作用持续时间
Ann Allergy. 1993 Feb;70(2):123-6.
10
Effect of cromolyn sodium (disodium cromoglycate) on the peripheral eosinophilia of asthmatic children.
Ann Allergy. 1973 Mar;31(3):134-6.

引用本文的文献

1
Imaging of the airways by bronchoscintigraphy for the study of mucociliary clearance.通过支气管闪烁显像对气道进行成像以研究黏液纤毛清除功能。
Thorax. 1988 May;43(5):360-5. doi: 10.1136/thx.43.5.360.
2
Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurised inhaler and a dry powder inhaler.特布他林对哮喘患者和健康受试者通过定量吸入器和干粉吸入器吸入药物后黏液纤毛清除功能的影响。
Thorax. 1991 Nov;46(11):817-23. doi: 10.1136/thx.46.11.817.